Teva’s drug, Ajovy, has shown positive results in late-stage trials for preventing episodic migraines in children. This could mean a new treatment option for kids who suffer from this condition.
Teva’s drug, Ajovy, has shown positive results in late-stage trials for preventing episodic migraines in children. This could mean a new treatment option for kids who suffer from this condition.